Acura Pharmaceuticals (ACUR) has been awarded a patent by the USPTO relating to its Aversion polymer matrix technology when utilized with any water soluble drug of abuse, as well as certain opioid products being developed by the company. Certain claims in this patent are licensed to Pfizer (PFE) which utilizes the Aversion technology in its Oxecta tablets.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs